HEMOGLOBIN A1C MONITORING - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ Million by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 27 companies including many key and niche players such as -

Abbott Laboratories
ARKRAY, Inc.
Axis-Shield plc
Bayer Healthcare Diabetes Care
Beckman Coulter, Inc.


Click here to request a full list of companies covered in the report...

Code: MCP-1218
Price: $4950
Companies: 27
Pages: 229
Date: February 2014
Market Data Tables: 110

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definition and Scope of Study.....I-3  
   A Quick Primer.....II-11$100
   Growth Stimulants in a Nutshell.....II-2
Major Concerns.....II-2
1$100
   Increasing Diabetes Prevalence – A Major Growth Propeller.....II-3 1$100
   Table 1: Worldwide Prevalence of Diabetes Mellitus by Region (2013 & 2035) (includes corresponding Graph/Chart).....II-4

Table 2: Incidence of Diabetes in Select Countries (2013 & 2035) (includes corresponding Graph/Chart).....II-4
1$350
   Table 3: World's Health Expenditure on Diabetes by Region (2013E): Spending (in US$ Billion) by People Diagnosed with Diabetes in the Age Group 20-79 Years to Treat Diabetes and Manage Associated Complications (includes corresponding Graph/Chart).....II-5

Table 4: Global Expenditure on Diabetes Treatment (2012): Spending (in US$ Billion) by Income Strata (includes corresponding Graph/Chart).....II-5
Rapidly Aging Demographics and Growing Incidence of Diabetes: Major Driving
  Factors.....II-5
1$350
   Table 5: Elderly Population (60+ Years) as a Percentage of Total Population (2012 & 2050) (includes corresponding Graph/Chart).....II-61$350
   Table 6: Global Aging Population (60+) and their Proportion of Total Population (2012) (includes corresponding Graph/Chart).....II-71$350
   Increasing Obesity Levels Underpins Market Growth.....II-8
Table 7: Global Obesity Population (2013) (includes corresponding Graph/Chart).....II-8
1$350
   Table 8: Prevalence of Adult Obesity in Select Countries (2012) (includes corresponding Graph/Chart).....II-9
Developing Nations: Future Growth Opportunities.....II-9
1$350
   Increase in Healthcare Spending in Emerging Markets.....II-10
Table 9: Healthcare Spending as % of GDP in Select Countries (2011) (includes corresponding Graph/Chart).....II-10
1$350
   Manufacturers Focus on Offering Products for Developing Markets.....II-11
Near Patient Testing Gaining Ground.....II-11
Regular HbA1c Test Keeps Heart Risk at Bay.....II-11
Diabetes Diagnosis: Opportunities for HbA1c Testing.....II-11
1$100
   Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?.....II-12
Glycosylated Hemoglobin Tests: Paving Way for Early Stage Diabetes Diagnosis.....II-12
1$100
   Technology Developments Revolutionize Diagnostics in Diabetes Care.....II-13
POC Testing: Positive Opportunities in Store.....II-13
1$100
   Complex Competitive Environment Prevails in POC Diagnostics Market.....II-14
POC HbA1c Tests: Significant Advantages over Lab Tests.....II-14
1$100
   Major Testing Methods in POC HbA1c Tests.....II-15
Immunoassays.....II-15
Boronate Affinity Chromatography.....II-15
1$100
   Micro-Optical Detection Methods.....II-16
Select HbA1c POC Tests in the Market - A Comparison.....II-16
1$100
   Home Monitoring: Laced with Accuracy Concerns.....II-17
Glycated Albumin – A Potential Threat to HbA1c?.....II-17
1$100
   Higher Levels of Glycosylated Hemoglobin Increases Risk of Death.....II-18
Non-Invasive Glucose Meters and CBGM Devices Threatens HbA1c Market.....II-18
1$100
   ESC and ADA Release Revised Guidelines for HbA1c Testing.....II-191$100
   Competitive Landscape.....II-20
Table 10: Leading Players in the Global HbA1c Reagent Market (2012): Percentage Breakdown of Revenues for Bayer Diabetes Care, Siemens, and Others (includes corresponding Graph/Chart).....II-20
1$350
   What Causes Diabetes?.....II-21
Types of Diabetes.....II-21
1$100
   Major Types of Diabetes.....II-22
Likely Complications.....II-22
Nephropathy (Kidney Disease).....II-22
Diabetic Neuropathy (Nerve Damage).....II-22
1$100
   Retinopathy (Damage to the Eye and Blindness).....II-23
Poor Healing of Infections and Wounds.....II-23
Impotence in Men.....II-23
Periodontal Disease.....II-23
Cardiovascular Disease.....II-23
Interpreting the A1c Range.....II-23
1$100
   Blood Glucose Level Guidelines in the US.....II-24
A Glance at Key Diabetes Statistics.....II-24
Table 11: World Diabetes and Population Statistics (2013 & 2035) (includes corresponding Graph/Chart).....II-24
1$350
   Table 12: World Diabetes and Population Statistics (in Million) by Region (2013E & 2035P) - Breakdown by Africa, Middle East and North Africa, Europe, North America and Caribbean Region, South and Central America, South East Asia, and Western Pacific (includes corresponding Graph/Chart).....II-251$350
   Prevalence of Diabetes in Various Parts of the World.....II-26
Table 13: Global Prevalence of Diabetes Mellitus (in Million) by Gender (2013E) - Breakdown by Region for Africa, Middle East and North Africa, Europe, North America and Caribbean Region, South and Central America, South East Asia, and Western Pacific (includes corresponding Graph/Chart).....II-26
1$350
   Table 14: Global Prevalence of Diabetes Mellitus (in Million) by Age Group (2013) - Breakdown by Region for Africa, Middle East and North Africa, Europe, North America and Caribbean Region, South and Central America, South East Asia, and Western Pacific Region (includes corresponding Graph/Chart).....II-271$350
   Table 15: World Diabetes Market (2013 & 2035): Top 10 Regions with Highest Number of People Diagnosed with Diabetes (in Million) in Age Group 20-79 years (includes corresponding Graph/Chart).....II-281$350
   Table 16: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region (2013E) (includes corresponding Graph/Chart).....II-29

Table 17: Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region (2013E) (includes corresponding Graph/Chart).....II-29
1$350
   Therapeutic Options for Diabetes.....II-30
Oral Medications for Type 2 Diabetes.....II-30
1$100
   Side Effects of Insulin Therapy.....II-31
Maintaining A1c Test Result Below 7%.....II-31
Common Diabetes Management Practices.....II-31
1$100
   Hemoglobin – A Brief.....II-32
Hemoglobin A1c- Description.....II-32
HbA1c Monitoring.....II-32
What is A1c?.....II-32
1$100
   1. HbA1c Laboratory Testing.....II-33
2. HbA1c Point of Care Testing & Self-Monitoring.....II-33
Hemoglobin A1c (HbA1c) Test.....II-33
1$100
   Interpreting HbA1c Test Readings.....II-34
Result of Hemoglobin A1c Test.....II-34
Clinical Use of A1c Testing.....II-34
1$100
   Advantages of A1c Assessment & Interpretation.....II-35
Risks Associated with HbA1c Testing.....II-35
Methods of Measurement for Glycohemoglobin.....II-35
1$100
   Why Opt for HbA1c Testing?.....II-36
The Diabetes Control & Complications Trial (DCCT).....II-36
The Kumamoto and UK Prospective Studies.....II-36
Glycemia Tests Used in Monitoring Diabetes.....II-36
1$100
   Urine Glucose Testing.....II-37
Glycated Protein Testing.....II-37
Table 18: Relation Between A1c Level and Mean Plasma Glucose Levels.....II-37
1$350
   HbA1c Test Types.....II-38
HbA1c Laboratory Testing.....II-38
Analytical Techniques Used for Quantifying HbA1c in Labs.....II-38
Standardization of HbA1c Results.....II-38
1$100
   Table 19: CAP Accuracy Grading for HbA1c Measurements (2007-2013).....II-39
Select Laboratory-based HbA1c Testing Products/Analyzers.....II-39
3$350
   HbA1c Point of Care Testing & Self-Monitoring.....II-421$100
   Select Point of Care HbA1c Testing Products/ Analyzers.....II-432$125
   Standardization of Glycated Hemoglobin Testing.....II-451$100
   NGSP Standardization of HbA1c.....II-46
IFCC Standardization of HbA1c.....II-46
HbA1c Reporting.....II-46
1$100
   A1c (%) and Corresponding eAG Number (in mg/dl or mmol/l).....II-471$100
   Piramal Enterprises Unveils Instant QDx Range of Diagnostic Devices.....II-48
Roche Launches Cobas B 101 System for Managing Metabolic Syndrome.....II-48
Convergys® Launches POC HbA1c Analyzer.....II-48
1$100
   Sanofi Showcases MyStar Extra® Self-Monitoring Meter .....II-49
Roche Unveils New HbA1c Test for Diagnosis of Diabetes.....II-49
1$100
   Erba Mannheim Unveils New Hb-Vario HPLC System.....II-50
EKF Launches Quo-Test POC HbA1c Analyzer.....II-50
Roche Receives FDA Approval for COBAS INTEGRA 800 Tina-quant HbA1cDx Assay.....II-50
1$100
   Beckman Coulter Gets FDA Clearance for Hemoglobin A1c Assay Tests.....II-51
Pointe Scientific Launches A1c Automated Assay for Beckman DXC 600 Analyser.....II-51
Dynacare Upgrades Hematology Software in Hemoglobin A1C Testing.....II-51
Tosoh Bioscience Introduces GX Glycohemoglobin Analyzer.....II-51
1$100
   Siemens Secures CE Marking for DCA HbA1c Test Kit.....II-52
EKF Obtains CE Mark for Quo-Lab POC HbA1c Analyser.....II-52
1$100
   Streck Launches A1c-Cellular Linearity Verification Material.....II-53
Abbott Obtains CE Marking for ARCHITECT HbA1c (IA) Fully Automated Assay.....II-53
1$100
   Tosoh Bioscience Develops ST AIA-PACK HbA1c Assay.....II-54
Trinity Obtains FDA Approval for Premier Hb9210 HbA1c Device.....II-54
1$100
   Siemens Launches Fortified Version of DCA Vantage Analyzer.....II-55
Tosoh Launches New Assay on its AIA-600II and AIA-360 Analyzers.....II-55
1$100
   Quest Diagnostics Sells HemoCue Business to Radiometer.....II-56
Techne Takes Over Bionostics.....II-56
1$100
   Express Diagnostics Takes Over Eveia Medical.....II-57
BioHermes Enters into Agreement to Acquire HbA1c Technology from Scripps
  Laboratories.....II-57
HemoCue America Inks 5-Year Agreement with ARC.....II-57
1$100
   Bio-Rad Laboratories Inks Development Agreement with Inpeco.....II-58
Danaher Acquires Beckman Coulter.....II-58
Alere Purchases Additional Shares of Axis-Shield.....II-58
1$100
   EKF Diagnostics Inaugurates New Manufacturing Plant in the UK.....II-59
MinuteClinic Signs Agreement with Axis-Shield.....II-59
Trinity Inks Distribution Agreement with Menarini for Premier Hb9210.....II-59
1$100
   Abbott Laboratories (US).....II-60
ARKRAY, Inc. (Japan).....II-60
1$100
   Axis-Shield plc (UK).....II-611$100
   Bayer Healthcare Diabetes Care (US).....II-62
Beckman Coulter, Inc. (US).....II-62
1$100
   Bio-Rad Laboratories Inc (US).....II-631$100
   Diazyme Laboratories Inc. (US).....II-64
EKF Diagnostics Holdings Plc (UK).....II-64
1$100
   HEMOCUE® AB (Sweden).....II-65
Infopia Co. Ltd. (South Korea).....II-65
Menarini Diagnostics Ltd. (UK).....II-65
1$100
   Roche Diagnostics (Switzerland).....II-66
Siemens Healthcare Diagnostics (Germany).....II-66
1$100
   Tosoh Bioscience, Inc (US).....II-67
Trinity Biotech plc (Ireland).....II-67
1$100
   Table 20: World Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart).....II-681$350
   Table 21: World Historic Review for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart).....II-691$350
   Table 22: World 15-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart).....II-701$350
   Table 23: World Recent Past, Current & Future Analysis for Laboratory-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart).....II-711$350
   Table 24: World Historic Review for Laboratory-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart).....II-721$350
   Table 25: World 15-Year Perspective for Laboratory- based HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart).....II-731$350
   Table 26: World Recent Past, Current & Future Analysis for Point-of-Care (POC)-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart).....II-741$350
   Table 27: World Historic Review for Point-of-Care (POC)-based HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart).....II-751$350
   Table 28: World 15-Year Perspective for Point-of-Care (POC)-based HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart).....II-761$350
   A. Market Analysis.....III-1
Outlook.....III-1
HbA1c – Increasingly Moving into Physician’s Office.....III-1
HbA1c Testing for Diabetes Detection Gains Support.....III-1
ADA Recommends HbA1c Test for Diabetes Diagnosis.....III-1
1$75
   ADA Recommends New Guidelines for HbA1c Testing for Certain Patients.....III-2
Rising Inclination towards CLIA-Waived Tests.....III-2
Need for Further Stringency in Requirements Arises.....III-2
1$75
   Healthcare Reform Legislation: Impact on Diabetes Diagnostics.....III-31$75
   US Near Patient HbA1c Testing – A Highly Consolidated Market.....III-4
Table 29: Leading Players in the US Near Patient HbA1c Testing Market (2013): Percentage Share Breakdown of Revenues for Siemens, Axis-Shield, and Others (includes corresponding Graph/Chart).....III-4
1$200
   Diabetes Statistics in North America and Caribbean Region.....III-5
Table 30: North American and Caribbean Regional Population and Diabetes Prevalence Statistics (2013E) - Top Regions with High Prevalence of Diabetes by Age Group and Gender (includes corresponding Graph/Chart).....III-5
1$200
   Table 31: Diabetes and Population Statistics in North America and Caribbean Region (2013 & 2035) (includes corresponding Graph/Chart).....III-6
Diabetes Statistics in the US – An Overview.....III-6
1$200
   Age Factor.....III-7
Table 32: Number of Diabetics by Gender in the US (2013E) (in ‘000s) (includes corresponding Graph/Chart).....III-7

Table 33: Number of Diabetics in the US by Age Group (2013E) (in ‘000s) (includes corresponding Graph/Chart).....III-7
1$200
   Prevalence by Race/Ethnicity.....III-8
Table 34: US Market for Diabetes (2012): Percentage Breakdown of Prevalence by Race/Ethnicity - Non-Hispanic Blacks and Non-Hispanic Whites (includes corresponding Graph/Chart).....III-8
1$200
   Mean HbA1c Scores at National Level.....III-9
Economic Burden of Diabetes in the US.....III-9
Table 35: Direct Medical Expenditure on Diabetes Management in the US (2012): Percentage Share Breakdown of Costs Incurred by Component (includes corresponding Graph/Chart).....III-9
1$200
   Table 36: Indirect Costs of Diabetes in the US (2012): Percentage Share Breakdown by Component (includes corresponding Graph/Chart).....III-10
Product Approvals/Launches.....III-10
3$200
   Strategic Corporate Developments.....III-132$150
   Key Players.....III-154$300
   B. Market Analytics.....III-19
Table 37: US Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-19
1$200
   Table 38: US Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011(includes corresponding Graph/Chart).....III-201$200
   Table 39: US 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-211$200
   A. Market Analysis.....III-22
Outlook.....III-22
Diabetes Statistics in Canada.....III-22
Table 40: Adult Diabetes Population by Gender in Canada (2013) (In ‘000s) (includes corresponding Graph/Chart).....III-22
1$200
   Table 41: Adult Diabetes Population by Age Group in Canada (2013) (In ‘000s) (includes corresponding Graph/Chart).....III-23
B. Market Analytics.....III-23
Table 42: Canadian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-23
1$200
   Table 43: Canadian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-241$200
   Table 44: Canadian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-251$200
   A. Market Analysis.....III-26
Outlook.....III-26
ARKRAY, Inc. – A Major Player.....III-26
1$75
   B. Market Analytics.....III-27
Table 45: Japanese Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-27
1$200
   Table 46: Japanese Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-281$200
   Table 47: Japanese 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-291$200
   A. Market Analysis.....III-30
Outlook.....III-30
Positive Outlook for Diabetes Diagnostics Market in Europe.....III-30
1$75
   Proven Efficacy and Benefits of POCT HbA1C Tests Spur Adoption.....III-31
Competitive Environment.....III-31
1$75
   Table 48: Leading Players in the European Point-of-Care HbA1c Tests Market (2011): Percentage Share Breakdown of Revenues for Axis-Shield, Hemocue, Siemens Healthcare Diagnostics, and Others (includes corresponding Graph/Chart).....III-32
A Glance at Key Diabetes Statistics in Europe.....III-32
Table 49: Diabetes and Population Statistics in Europe (2013 & 2035) (includes corresponding Graph/Chart).....III-32
1$200
   Table 50: European Population and Diabetes Prevalence Statistics (2013E) - Select Regions with High Prevalence of Diabetes for Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart).....III-331$200
   B. Market Analytics.....III-34
Table 51: European Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-34
1$200
   Table 52: European Historic Review for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-351$200
   Table 53: European Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-361$200
   Table 54: European Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-371$200
   Table 55: European 15-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-381$200
   Table 56: European 15-Year Perspective for HbA1c Monitoring by Segment -Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-391$200
   Market Analysis.....III-40
Table 57: French Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-40
1$200
   Table 58: French Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-411$200
   Table 59: French 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-421$200
   A. Market Analysis.....III-43
Outlook.....III-43
Product Approvals/Introductions.....III-43
1$75
   Siemens Healthcare Diagnostics – A Key Player.....III-441$75
   B. Market Analytics.....III-45
Table 60: German Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-45
1$200
   Table 61: German Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-461$200
   Table 62: German 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-471$200
   Market Analysis.....III-48
Table 63: Italian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-48
1$200
   Table 64: Italian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-491$200
   Table 65: Italian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
Outlook.....III-51
Diabetes Statistics & Management – An Insight.....III-51
Rising Obesity Cases – Increased Risk of Diabetes.....III-51
1$75
   Type 1 Diabetes in Children.....III-52
Table 66: Number of Type 1 Diabetics Per 100,000 Children in Select Countries (2011) (includes corresponding Graph/Chart).....III-52
NHS England Launches Action for Diabetes Plan.....III-52
1$200
   Strategic Corporate Developments.....III-531$75
   Key Players.....III-542$150
   B. Market Analytics.....III-56
Table 67: UK Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-56
1$200
   Table 68: UK Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-571$200
   Table 69: UK 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-581$200
   A. Market Analysis.....III-59
Outlook.....III-59
Product Launch.....III-59
1$75
   B. Market Analytics.....III-60
Table 70: Spanish Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-60
1$200
   Table 71: Spanish Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-611$200
   Table 72: Spanish 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-621$200
   Market Analysis.....III-63
Market Analysis.....III-63
1$75
   Table 73: Russian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-641$200
   Table 74: Russian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-651$200
   Table 75: Russian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-661$200
   A. Market Analysis.....III-67
Outlook.....III-67
Strategic Corporate Developments.....III-67
2$150
   Key Players.....III-692$150
   B. Market Analytics.....III-71
Table 76: Rest of Europe Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-71
1$200
   Table 77: Rest of Europe Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-721$200
   Table 78: Rest of Europe 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-731$200
   A. Market Analysis.....III-74
Outlook.....III-74
Diabetes Statistics – An Overview.....III-74
1$75
   Table 79: Diabetes and Population Statistics in Western Pacific (2013 & 2035) (includes corresponding Graph/Chart).....III-751$200
   Table 80: Western Pacific Population and Diabetes Prevalence Statistics (2013E) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart).....III-761$200
   Table 81: Diabetes and Population Statistics in South East Asia (2013 & 2035) (includes corresponding Graph/Chart).....III-77

Table 82: South East Asian Population and Diabetes Prevalence Statistics (2013 Estimates) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart).....III-77
1$200
   B. Market Analytics.....III-78
Table 83: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-78
1$200
   Table 84: Asia-Pacific Historic Review for HbA1c Monitoring by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-791$200
   Table 85: Asia-Pacific 15-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-801$200
   Table 86: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-811$200
   Table 87: Asia-Pacific Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-821$200
   Table 88: Asia-Pacific 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-831$200
   A. Market Analysis.....III-84
Outlook.....III-84
Increasing Diabetes Incidence Spurs Growth in Diabetes Diagnostics Market.....III-84
1$75
   Strategic Corporate Development.....III-851$75
   B. Market Analytics.....III-86
Table 89: Chinese Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-86
1$200
   Table 90: Chinese Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-871$200
   Table 91: Chinese 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-881$200
   A. Market Analysis.....III-89
Outlook.....III-89
HbA1c Testing on Growth Spree.....III-89
Growth Stimulants & Challenges in a Nut Shell.....III-89
1$75
   Rising Diabetes Cases – Opportunities for HbA1c Monitoring Market.....III-90
Product Launch.....III-90
1$75
   B. Market Analytics.....III-91
Table 92: Indian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-91
1$200
   Table 93: Indian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-921$200
   Table 94: Indian 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-931$200
   A. Market Analysis.....III-94
Outlook.....III-94
Diabetes Statistics in Australia.....III-94
Table 95: Diabetes Population Breakdown by Age Group in Australia (2011-12) (includes corresponding Graph/Chart).....III-94
1$200
   Infopia Co. Ltd. (South Korea) – A Major Player.....III-95
B. Market Analytics.....III-95
Table 96: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-95
1$200
   Table 97: Rest of Asia-Pacific Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-961$200
   Table 98: Rest of Asia-Pacific 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-971$200
   A. Market Analysis.....III-98
Outlook.....III-98
Diabetes in Latin America – A Glance at Key Statistics.....III-98
1$75
   Table 99: Diabetes and Population Statistics in Central and South America (2013 & 2035) (includes corresponding Graph/Chart).....III-99

Table 100: Central and South American Population and Diabetes Prevalence Statistics (2013 Estimates) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart).....III-99
1$200
   B. Market Analytics.....III-100
Table 101: Latin American Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-100
1$200
   Table 102: Latin American Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-1011$200
   Table 103: Latin American 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-1021$200
   A. Market Analysis.....III-103
Outlook.....III-103
Diabetes Statistics in Africa and the Middle East.....III-103
Table 104: African Diabetes and Population Statistics (2013 & 2035) (includes corresponding Graph/Chart).....III-103
1$200
   Table 105: African Population and Diabetes Prevalence Statistics (2013) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart).....III-1041$200
   Table 106: Diabetes and Population Statistics in Middle East and North Africa (2013 & 2035) (includes corresponding Graph/Chart).....III-1051$200
   Table 107: Middle East and North African Population and Diabetes Prevalence Statistics (2013 Estimates) - Select Regions with High Prevalence of Diabetes for Various Age Groups (20-39, 40-59, and 60-79) and Gender (includes corresponding Graph/Chart).....III-1061$200
   B. Market Analytics.....III-107
Table 108: Rest of World Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2012 through 2020 (includes corresponding Graph/Chart).....III-107
1$200
   Table 109: Rest of World Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2011 (includes corresponding Graph/Chart).....III-1081$200
   Table 110: Rest of World 15-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2006, 2014 and 2020 (includes corresponding Graph/Chart).....III-1091$200
  
Total Companies Profiled: 27 (including Divisions/Subsidiaries - 35)

Region/Country Players

The United States 14 Canada 1 Japan 3 Europe 14 Germany 3 The United Kingdom 5 Italy 1 Rest of Europe 5 Asia-Pacific (Excluding Japan) 3
Click here to request a full table of contents and more details on this project.